International Stem Cell Corp (ISCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34 | -331 | -354 | -11 | -9 |
| Depreciation Amortization | 51 | 218 | 166 | 111 | 56 |
| Accounts receivable | 59 | N/A | 417 | 181 | -58 |
| Accounts payable and accrued liabilities | 29 | -186 | -130 | -36 | 125 |
| Other Working Capital | 19 | -324 | -51 | -247 | -226 |
| Other Operating Activity | 92 | 955 | 205 | 171 | 89 |
| Operating Cash Flow | $216 | $332 | $253 | $169 | $-23 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15 | -1 | -1 | -1 | N/A |
| Purchase Sale Intangibles | N/A | -10 | -7 | -3 | N/A |
| Other Investing Activity | 0 | -10 | -7 | -3 | 0 |
| Investing Cash Flow | $-15 | $-11 | $-8 | $-4 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 250 | 250 | 250 | 250 |
| Financing Cash Flow | $N/A | $250 | $250 | $250 | $250 |
| Beginning Cash Position | 742 | 171 | 171 | 171 | 171 |
| End Cash Position | 943 | 742 | 666 | 586 | 398 |
| Net Cash Flow | $201 | $571 | $495 | $415 | $227 |
| Free Cash Flow | |||||
| Operating Cash Flow | 216 | 332 | 253 | 169 | -23 |
| Capital Expenditure | -15 | -1 | -1 | -1 | 0 |
| Free Cash Flow | 201 | 331 | 252 | 168 | -23 |